Guru Ownership Trend
Guru Analysis for United Therapeutics Corporation (UTHR)
United Therapeutics Corporation (UTHR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.92 B.
Top institutional holders include Renaissance Technologies and Cliff Asness.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $78.74 M net inflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 302.1%. Conversely, Jeremy Grantham reduced exposure by 95.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for United Therapeutics Corporation (UTHR)
Major holders include Renaissance Technologies ($930.29 M), Cliff Asness ($624.51 M), Steven Cohen ($90.71 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 3.58 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $78.74 M, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited UTHR. The total reported sell value was $138.11 M.
Yes, 1 managers opened new positions in UTHR, and 4 increased their existing holdings. The total reported buy value was $216.85 M.
